Ambra Bioscience Overview
- Year Founded
-
2014

- Status
-
Private
- Employees
-
15

- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$2.01M
Ambra Bioscience General Information
Description
Provider of dietary supplements and medical foods intended to help people control blood sugar levels. The company's supplements focus on the physiologic release of hormones produced by L-cells in the lower gut which affects hunger, glucose regulation, inflammatory response and mood, enabling people to maintain a healthy diet.
Contact Information
Website
www.ambrabio.com
Formerly Known As
Ambra BioHealth
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Food Products
Other Industries
Biotechnology
Drug Discovery
Other Consumer Non-Durables
Personal Products
Primary Office
- 1850 Diamond Street
- Suite 305
- San Marcos, CA 92078
- United States
+1 (858) 000-0000
Ambra Bioscience Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Seed Round | 31-Jul-2017 | $2.01M | 00.000 | Completed | Generating Revenue | |
2. Angel (individual) | 26-Sep-2016 | 00000 | 00.000 | Completed | Startup | |
1. Seed Round | 02-Feb-2015 | $1.17M | $1.17M | Completed | Startup |
Ambra Bioscience Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Provider of dietary supplements and medical foods intended to help people control blood sugar levels. The company's supp
Food Products
San Marcos, CA
15
As of 2018
00.000
000000000
00.000
Ambra Bioscience Competitors (2)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Nutrisystem | Private Equity-Backed | Fort Washington, PA | 000 | 00000 | 000000000 | 00000 |
00 | Formerly PE-Backed | New York, NY | 0000 | 000.00 | 00000000000 | 000.00 |
Ambra Bioscience Patents
Ambra Bioscience Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20210084956-A1 | Compositions and methods for hunger control and weight management | Inactive | 23-Feb-2018 | 00000000000 | |
EP-2916828-A1 | Gras enteric coating formulations and methods of making and using same | Inactive | 07-Nov-2012 | 000000000 | |
US-20140127299-A1 | Gras enteric coating formulations and methods of making and using same | Inactive | 07-Nov-2012 | 000000000 | 0 |
US-20150150894-A1 | Chemosensory receptor ligand-based therapies | Active | 20-Apr-2009 | 00000000000 | |
US-9526741-B2 | Chemosensory receptor ligand-based therapies | Active | 20-Apr-2009 | A61K31/7016 |
Ambra Bioscience Executive Team (3)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Martin Brown | Co-Founder, Chief Executive Officer & Board Member |
Ambra Bioscience Board Members (4)
Name | Representing | Role | Since |
---|---|---|---|
Joseph Zakrzewski | Self | Board Member | 000 0000 |
Martin Brown | Ambra Bioscience | Co-Founder, Chief Executive Officer & Board Member | 000 0000 |
Nancy Stubbs | Self | Board Member | 000 0000 |